Ohio State University
Clinical trials sponsored by Ohio State University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Sip your way sharper? ketone drink tested against sleep loss Results expected Sep 2026 (estimated)
- New Step-by-Step care model aims to halt psychosis in its tracks Results expected Sep 2026 (estimated)
- Heart shield after pregnancy: statin trial targets lasting damage Results expected Sep 2026 (estimated)
- New study aims to better detect pneumonia in seniors Results expected Sep 2026 (estimated)
- Ketone supplements put to the test: which one works best? Results expected Oct 2026 (estimated)
-
Could a One-Time X-Ray calm the deadly lung inflammation of severe COVID-19?
Disease control Stopped earlyThis phase II trial tests whether a single, ultra-low dose of radiation to both lungs can reduce the dangerous inflammation caused by COVID-19 pneumonia in critically ill patients who need a ventilator. The treatment, a one-time 80 cGy X-ray session, aims to calm the immune syste…
Phase 2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Promising c. diff drug fails to prove benefit in small, halted trial
Disease control Stopped earlyThis study tested whether an extra dose of bezlotoxumab, a drug that blocks the harmful toxin made by C. diff bacteria, could help very sick patients recover after emergency colon surgery. Only 5 people took part before the study was stopped early. The goal was to see if the drug…
Phase 4 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Three knee shots go Head-to-Head for lasting arthritis relief
Symptom relief Stopped earlyResearchers at Ohio State University are running a double-blind, randomized trial to compare three single-dose injections for knee osteoarthritis: Zilretta, Synvisc-One, and Monovisc. The study enrolls adults aged 25 to 85 with painful knee osteoarthritis that continues despite p…
Phase 4 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Feeding tube showdown: are expensive new tubes worth it?
Knowledge-focused Stopped earlyThis study compared two types of feeding tubes used for long-term nutrition: standard balloon tubes and newer capsule dome tubes. The goal was to see if the more expensive capsule tubes last longer and are more cost-effective. The study planned to enroll adults needing tube feedi…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Tiny study probes why clozapine beats other schizophrenia drugs
Knowledge-focused Stopped earlyThis study aimed to compare the effects of clozapine versus other antipsychotic medications on inflammation in people with treatment-resistant schizophrenia. Researchers measured inflammatory markers like interleukin-6 in a small group of participants. The study was terminated ea…
Phase 4 • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
What makes drivers rage? simulator study explores triggers
Knowledge-focused Stopped earlyThis study used driving simulators to see what makes people drive aggressively or experience road rage. Researchers tested things like music, bumper stickers, and roadside trash to see if they affect driving behavior. The study included 85 adults from Ohio with valid driver's lic…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New survey aims to better measure life quality in pituitary tumor patients
Knowledge-focused Stopped earlyThis study tested a new questionnaire called Prolac-10 to see if it can accurately measure quality of life in people with prolactinoma (a type of pituitary tumor) who are starting medical treatment. Only 8 people took part before the study was stopped early. The goal was to check…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC